Go Back
Innovating Capital
Innovating Capital, a venture fund founded in 2017, focuses on Pre-Seed to Series D stages, with a primary interest in BioTech, Healthcare, and Medical Device sectors. Partnered with Pen King, the fund has invested in 26 companies, with 6 successful exits, including Cresilon, Inc. Based in New York, Innovating Capital's portfolio spans financial, cybersecurity, insurance, and life sciences industries. For more information, visit their website at www.innovating.capital.
About
About
About
Bio
Innovating Capital is a premier technology fund with a focus on financial, cybersecurity, insurance, and life sciences.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Pen King
Bio
Innovating Capital is a premier technology fund with a focus on financial, cybersecurity, insurance, and life sciences.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Pen King
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Medical Device
Number of investments
26
Number of exits
6
Fund Type
Venture Fund
Portfolio Companies
Cresilon, Inc.
Innovating Capital
Innovating Capital, a venture fund founded in 2017, focuses on Pre-Seed to Series D stages, with a primary interest in BioTech, Healthcare, and Medical Device sectors. Partnered with Pen King, the fund has invested in 26 companies, with 6 successful exits, including Cresilon, Inc. Based in New York, Innovating Capital's portfolio spans financial, cybersecurity, insurance, and life sciences industries. For more information, visit their website at www.innovating.capital.
About
Bio
Innovating Capital is a premier technology fund with a focus on financial, cybersecurity, insurance, and life sciences.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Pen King
Fund
Fund Focus
BioTech, Healthcare, Medical Device
Number of investments
26
Number of exits
6
Fund Type
Venture Fund
Portfolio Companies
Cresilon, Inc.